I'll probably share more about $HIMS in the coming days but for now I wanted to say the FDA/HHS panel hearing was quite good. I listened to 8+ hours over the past 2 days... much of it was over my head... however I did enjoy listening to the pro-peptide speakers who had much stronger cases than the anti-peptide speakers. The pro-peptide speakers were using real world examples across thousands of patients. The anti-peptide speakers were basically just focused on the lack of human trial data (which is legit). I already had a good understanding of BPC-157 and TB-500 because I've been using them on and off for 2+ years however the commentary around Epitalon, Semax and Mots-C was the most interesting to me. Of the three, I'm most excited about Mots-C and will begin integrating it into my dai
View on X ↗